Weak lead generation: Have we reached the bottom?
17/04/25 -"Rentokil reported Q1 25 sales figures slightly below our expectations (-2%). This was primarily due to underperformance in North America. The group reported organic growth of 1.8% yoy, as well as ..."
Pages
57
Language
English
Published on
17/04/25
You may also be interested by these reports :
08/05/25
Organic sales growth and operating margin improvement were in line with expectations, with all divisions contributing to the overall performance. At ...
30/04/25
Rentokil’s (Buy; UK) share price has declined by 11% since we last teased about it in May 2024. Things started out well when the activist investor ...
25/04/25
BV’s Q1 sales figures were marginally ahead of the consensus in absolute terms, but exceeded expectations on organic growth. Sales growth was ...
24/04/25
SGS’s Q1 organic print was within the group’s guidance of 5-7%, with the organic growth 20bps below the company-compiled consensus, whereas absolute ...